MultiplexDX International

MultiplexDX is an international corporation established in 2015 consisting of two units: MultiplexDX Inc. located in Maryland US and MultiplexDX s.r.o. located in Slovakia. Our main goal is to eliminate cancer misdiagnosis by launching 98% accurate, quantitative and accessible diagnostic tests. We also operate a boutique oligohouse offering highly specialized custom oligonucleotides to the research community.

Our mission:

By transforming breast cancer treatment non-responders into responders and ensuring durable responses, we aim to drastically increase survival rates by at least 50%.

Objectives of the company are:

i) development of the technologies and the products for molecular diagnostic markets superior to currently available products;

ii) core facility service using proprietary Multiplex TM technology

iii) development of hi-tech 3D digital pathology services.

Find out more about MultiplexDX on our official website and in social media:

http://www.multiplexdx.com/

https://www.facebook.com/multiplexdx/

https://twitter.com/@multiplexdx

http://bit.ly/MDXGooglePlus

https://www.youtube.com/c/multiplexdx